An In Vitro Model to Evaluate the Impact of the Soluble Factors from the Colonic Mucosa of Collagenous Colitis Patients on T Cells: Enhanced Production of IL-17A and IL-10 from Peripheral CD4(+) T CellsShow others and affiliations
2014 (English)In: Mediators of Inflammation, ISSN 0962-9351, E-ISSN 1466-1861, article id 879843
Article in journal (Refereed) Published
Abstract [en]
Soluble factors from intestinal mucosal cells contribute to immune homeostasis in the gut. We have established an in vitro model to investigate the regulatory role of soluble factors from inflamed intestinal mucosa of collagenous colitis (CC) patients in the differentiation of T cells. Peripheral blood CD4(+) T cells from healthy donors were polyclonally activated in the presence of conditioned medium (CM) generated from denuded biopsies (DNB) or isolated lamina propria mononuclear cells (LPMCs) from mucosal biopsies from CC patients compared to noninflamed controls, to determine proliferation and secretion of cytokines involved in T-cell differentiation. Compared to controls, we observed significantly increased production of the proinflammatory cytokines IFN-gamma, IL-17A, IL-6, and IL-1 beta and the anti-inflammatory cytokines IL-4 and IL-10 in the presence of CC-DNB-CM. The most pronounced effect of CC-LPMC-CM on peripheral CD4(+) T cells was a trend towards increased production of IL-17A and IL-10. A trend towards reduced inhibition of T-cell proliferation was noted in the presence of CC-DNB-CM. In conclusion, our in vitro model reveals implications of soluble factors from CC colonic mucosa on peripheral T cells, enhancing their production of both pro-and anti-inflammatory cytokines.
Place, publisher, year, edition, pages
New York, USA: Hindawi Publishing Corporation, 2014. article id 879843
National Category
Cell and Molecular Biology Immunology in the medical area
Research subject
Immunology; Cell Research
Identifiers
URN: urn:nbn:se:oru:diva-39815DOI: 10.1155/2014/879843ISI: 000344673500001PubMedID: 25332518Scopus ID: 2-s2.0-84912000717OAI: oai:DiVA.org:oru-39815DiVA, id: diva2:772126
Note
Funding Agencies:
Swedish Society of Medicine (Bengt Ihre Foundation) SLS-176271/2011 98031/2010
Nyckelfonden at Örebro University Hospital
Örebro University Hospital Research Foundation
Lars Hierta Foundation
2014-12-162014-12-162020-12-01Bibliographically approved